Skip to content
Home/Companies/Biotech/Addex Therapeutics
AT

Addex Therapeutics

Biotech·Switzerland·Exited 2012·Held 4yr

Addex Therapeutics is a healthcare / biotech company, headquartered in Switzerland.

Entry
2008
Hold
4yr
Exit
2012
Est. EV
–

Who owns Addex Therapeutics?

Addex Therapeutics was owned by Sofinnova Partners through Sofinnova Capital VI (2008 vintage) from 2008 to 2012.

Hand-verified · updated 2026-04-21

Sofinnova Partners
Investor
Sofinnova Partners
Sofinnova Capital VI · 2008 · Life Sciences VC

Key facts

HQSwitzerland
SectorHealthcare / Biotech
Exit Type
–
Buyer
–
MOIC
–
Exit Year
2012

More from Sofinnova Capital VI

Other portfolio companies in the same fund.

ABIONYX Pharma
Exited 2020
BiotechFrance· 2010
DBV
Exited 2014
BiotechFrance· 2010
Omthera Pharmaceuticals
Exited 2013
BiotechUS· 2010
to
Ablynx NV
Exited 2018
BiotechBelgium· 2008
to
Movetis
Exited 2010
BiotechBelgium· 2008
to
Noxxon Pharma
Exited 2016
BiotechGermany· 2008

More PE-backed in Biotech

Comparable biotech deals from other GPs.

InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
2NA FISH
Active
Gruenderfonds RuhrGermany· 2026
Data refreshed weekly · Sourced from public filings